![[Etoday] C&R Research Expands Performance In The First Half Of The Year… Sales KRW 25.6 Billion](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Etoday] C&R Research expands performance in the first half of the year… Sales KRW 25.6 billion
C&R Research, a clinical trial consignment agency, achieved its highest performance since listing. C&R Research announced on the 14th that…
[Hankyung] C&R Research helps develop treatments for rare diseases through ‘external control group’
C&R Research, Korea's first contract research organization (CRO) company, supports the development of treatments for rare and incurable diseases…
[Edaily] C&R Research selected for government task related to standardization of clinical trial data
C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, is carrying out 'data standardization and application tasks…
[Sedaily] “Re-pursuing the acquisition of a Clinical Trial consignment agency… Taking the lead to Decentralized Clinical Trial.”
“For a domestic blockbuster new drug to be created, domestic contract research organizations (CROs) must first secure global-level capabilities. This…
[Yakup] C&R Research “The answer to success in developing advanced biopharmaceuticals is cooperation and communication.”
Expert opinions were presented that close cooperation between various fields of expertise, including companies, regulatory agencies, and CROs (drug development…